Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing's syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing's syndrome.


Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 04 03 2022
accepted: 21 05 2022
pubmed: 29 5 2022
medline: 15 9 2022
entrez: 28 5 2022
Statut: ppublish

Résumé

In selected cases of severe Cushing's syndrome due to uncontrolled ACTH secretion, bilateral adrenalectomy appears unavoidable. Compared with unilateral adrenalectomy (for adrenal Cushing's syndrome), bilateral adrenalectomy has a perceived higher perioperative morbidity. The aim of the current study was to compare both interventions in endogenous Cushing's syndrome regarding postoperative outcomes. We report a single-center, retrospective cohort study comparing patients with hypercortisolism undergoing bilateral vs. unilateral adrenalectomy during 2008-2021. Patients with adrenal Cushing's syndrome due to adenoma were compared with patients with ACTH-dependent Cushing's syndrome (Cushing's disease and ectopic ACTH production) focusing on postoperative morbidity and mortality as well as long-term survival. Of 83 patients with adrenalectomy for hypercortisolism (65.1% female, median age 53 years), the indication for adrenalectomy was due to adrenal Cushing's syndrome in 60 patients (72.2%; 59 unilateral and one bilateral), and due to hypercortisolism caused by Cushing's disease (n = 16) or non-pituitary uncontrolled ACTH secretion of unknown origin (n = 7) (27.7% of all adrenalectomies). Compared with unilateral adrenalectomy (n = 59), patients with bilateral adrenalectomy (n = 24) had a higher rate of severe complications (0% vs. 33%; p < 0.001) and delayed recovery (median: 10.2% vs. 79.2%; p < 0.001). Using the MTL30 marker, patients with bilateral adrenalectomy fared worse than patients after unilateral surgery (MTL30 positive: 7.2% vs. 25.0% p < 0.001). Postoperative mortality was increased in patients with bilateral adrenalectomy (0% vs. 8.3%; p = 0.081). While unilateral adrenalectomy for adrenal Cushing's syndrome represents a safe and definitive therapeutic option, bilateral adrenalectomy to control ACTH-dependent extra-adrenal Cushing's syndrome or Cushing's disease is a more complicated intervention with a mortality of nearly 10%.

Identifiants

pubmed: 35633419
doi: 10.1007/s00423-022-02568-8
pii: 10.1007/s00423-022-02568-8
pmc: PMC9467939
doi:

Substances chimiques

Adrenocorticotropic Hormone 9002-60-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2481-2488

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

Gastric Cancer. 2021 Jul;24(4):959-969
pubmed: 33576929
Compr Physiol. 2014 Apr;4(2):739-69
pubmed: 24715566
J Clin Endocrinol Metab. 2009 Sep;94(9):3365-71
pubmed: 19509101
Eur J Endocrinol. 2020 Apr;182(4):R29-R58
pubmed: 31999619
PLoS One. 2020 Aug 28;15(8):e0238473
pubmed: 32857807
Br J Surg. 2021 Sep 27;108(9):1112-1119
pubmed: 33990837
Rev Endocr Metab Disord. 2010 Jun;11(2):117-26
pubmed: 20544290
Int J Surg. 2021 Feb;86:24-31
pubmed: 33429078
Eur J Endocrinol. 2015 Oct;173(4):M23-32
pubmed: 25994948
Chirurg. 2017 Nov;88(11):977-982
pubmed: 28761965
J Clin Endocrinol Metab. 2001 Jan;86(1):117-23
pubmed: 11231987
Ann Surg. 2013 Jul;258(1):1-7
pubmed: 23728278
Best Pract Res Clin Endocrinol Metab. 2019 Oct;33(5):101296
pubmed: 31331729
Dtsch Arztebl Int. 2019 Nov 1;116(44):739-746
pubmed: 31774053
Clin Epidemiol. 2015 Apr 17;7:281-93
pubmed: 25945066
BJS Open. 2020 Apr;4(2):310-319
pubmed: 32207577
Endocr Rev. 1994 Dec;15(6):752-87
pubmed: 7705280
BJS Open. 2019 May 03;3(5):672-677
pubmed: 31592096
Ann Surg Oncol. 2020 Oct;27(10):3851-3857
pubmed: 32388739
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Endocr Rev. 2015 Aug;36(4):385-486
pubmed: 26067718
Surgery. 2001 Oct;130(4):629-34; discussion 634-5
pubmed: 11602893
Ann N Y Acad Sci. 2002 Sep;970:134-44
pubmed: 12381548
J Clin Endocrinol Metab. 2013 Oct;98(10):3939-48
pubmed: 23956347
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
J Clin Endocrinol Metab. 2013 Jun;98(6):2277-84
pubmed: 23533241

Auteurs

Joachim Reibetanz (J)

Department of General, Visceral, Transplant, Vascular and Pediatric Surgery at Würzburg University Hospital, Würzburg, Germany.

Matthias Kelm (M)

Department of General, Visceral, Transplant, Vascular and Pediatric Surgery at Würzburg University Hospital, Würzburg, Germany.

Konstantin L Uttinger (KL)

Department of General, Visceral, Transplant, Vascular and Pediatric Surgery at Würzburg University Hospital, Würzburg, Germany.
Department of Visceral, Transplant, Thoracic and Vascular Surgery at Leipzig University Hospital, Leipzig, Germany.

Miriam Reuter (M)

Division of Endocrinology and Diabetes, Department of Medicine I, University Hospital, University of Würzburg, 97080, Würzburg, Germany.

Nicolas Schlegel (N)

Department of General, Visceral, Transplant, Vascular and Pediatric Surgery at Würzburg University Hospital, Würzburg, Germany.

Mohamed Hankir (M)

Department of General, Visceral, Transplant, Vascular and Pediatric Surgery at Würzburg University Hospital, Würzburg, Germany.

Verena Wiegering (V)

Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Children's Hospital, University of Wuerzburg, Josef-Schneiderstr. 2, 97080, Würzburg, Germany.

Christoph-Thomas Germer (CT)

Department of General, Visceral, Transplant, Vascular and Pediatric Surgery at Würzburg University Hospital, Würzburg, Germany.
Comprehensive Cancer Center Mainfranken, University of Würzburg Medical Centre, Würzburg, Germany.

Martin Fassnacht (M)

Division of Endocrinology and Diabetes, Department of Medicine I, University Hospital, University of Würzburg, 97080, Würzburg, Germany.
Comprehensive Cancer Center Mainfranken, University of Würzburg Medical Centre, Würzburg, Germany.

Johan Friso Lock (JF)

Department of General, Visceral, Transplant, Vascular and Pediatric Surgery at Würzburg University Hospital, Würzburg, Germany.

Armin Wiegering (A)

Department of General, Visceral, Transplant, Vascular and Pediatric Surgery at Würzburg University Hospital, Würzburg, Germany. Wiegering_a@ukw.de.
Comprehensive Cancer Center Mainfranken, University of Würzburg Medical Centre, Würzburg, Germany. Wiegering_a@ukw.de.
Department of Biochemistry and Molecular Biology, University of Würzburg, Würzburg, Germany. Wiegering_a@ukw.de.
Department of General, Visceral, Transplant, Vascular and Paediatric Surgery, Medical Centre, Julius Maximilians University of Würzburg, Oberduerrbacher Strasse 6, 97080, Würzburg, Germany. Wiegering_a@ukw.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH